These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15221968)

  • 1. Prognostic value of soluble P-selectin levels in colorectal cancer.
    Ferroni P; Roselli M; Martini F; D'Alessandro R; Mariotti S; Basili S; Spila A; Aloe S; Palmirotta R; Maggini A; Del Monte G; Mancini R; Graziano F; Cosimelli M; Guadagni F
    Int J Cancer; 2004 Sep; 111(3):404-8. PubMed ID: 15221968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sE-selectin levels and carcinoembryonic antigen mRNA-expressing cells in peripheral blood as prognostic factors in colorectal cancer patients.
    Ferroni P; Roselli M; Spila A; D'Alessandro R; Portarena I; Mariotti S; Palmirotta R; Buonomo O; Petrella G; Guadagni F
    Cancer; 2010 Jun; 116(12):2913-21. PubMed ID: 20336782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin adhesion proteins (P-, L- and E-selectins) as biomarkers in colorectal cancer.
    Korniluk A; Kamińska J; Kiszło P; Kemona H; Dymicka-Piekarska V
    Biomarkers; 2017 Nov; 22(7):629-634. PubMed ID: 27775438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of soluble CD40 ligand as inflammatory biomarker in colorectal cancer patients.
    Dymicka-Piekarska V; Korniluk A; Gryko M; Siergiejko E; Kemona H
    Int J Biol Markers; 2014 Sep; 29(3):e261-7. PubMed ID: 24706377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum carcinoembryonic antigen and endothelial cell adhesion molecules in colorectal cancer.
    Roselli M; Guadagni F; Martini F; Spila A; Mariotti S; D'Alessandro R; Aloe S; Gazzaniga PP; Basili S; Cosimelli M; Ferroni P
    Oncology; 2003; 65(2):132-8. PubMed ID: 12931019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of PDGF-AB and sP-selectin concentrations in relation to platelet count in patients with colorectal cancer before and after surgical treatment.
    Mantur M; Koper O; Snarska J; Sidorska A; Kruszewska-Wnorowska K
    Pol Arch Med Wewn; 2008 Jun; 118(6):345-50. PubMed ID: 18619189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in platelet CD 62P expression and soluble P-selectin concentration in surgically treated colorectal carcinoma.
    Dymicka-Piekarska V; Matowicka-Karna J; Osada J; Kemona H; Butkiewicz AM
    Adv Med Sci; 2006; 51():304-8. PubMed ID: 17357330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
    Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of methylated free circulating DNA in colorectal cancer.
    Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
    Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.
    Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H
    Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
    Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
    Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin serum biomarkers in patients with colorectal cancer.
    Holdenrieder S; Stieber P; Liska V; Treska V; Topolcan O; Dreslerova J; Matejka VM; Finek J; Holubec L
    Anticancer Res; 2012 May; 32(5):1971-6. PubMed ID: 22593474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen PM
    World J Gastroenterol; 2005 Apr; 11(14):2166-70. PubMed ID: 15810086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
    J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sE-selectin and ICAM-1) concentration?
    Dymicka-Piekarska V; Kemona H
    Thromb Res; 2009 May; 124(1):80-3. PubMed ID: 19136145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study.
    Graf ME; Sookthai D; Johnson T; Schübel R; Maldonado SG; Pletsch-Borba L; Katzke V; Bugert P; Hoffmeister M; Kaaks R; Kühn T
    Int J Cancer; 2018 Dec; 143(11):2659-2667. PubMed ID: 29923180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
    Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
    Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of plasma ORM2 levels in patients with stage II colorectal cancer.
    Gao F; Zhang X; Whang S; Zheng C
    Ann Clin Lab Sci; 2014; 44(4):388-93. PubMed ID: 25361921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.